Lung Cancer Clinical Trial

Prospective Post-market Data Collection for Ion Endoluminal System to Understand CT to Body Divergence

Summary

The goal of this study is to collect post-market data for the Ion Endoluminal System to understand CT to body divergence.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Age of 18 years or older

Undergoing a lung biopsy procedure with Ion System
Have peripheral pulmonary lesion (5th bronchial generation or higher)
Willingness to participate as demonstrated by signing the informed consent

Exclusion Criteria:

Unable to provide informed consent

Presence of bilateral nodules intended to be biopsied during procedure
The presence of medical conditions contraindicating general anesthesia or bronchoscopic biopsy
Vulnerable population (e.g., prisoners, mentally disabled)

Study is for people with:

Lung Cancer

Estimated Enrollment:

30

Study ID:

NCT04735341

Recruitment Status:

Completed

Sponsor:

Intuitive Surgical

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

FirstHealth of the Carolinas Moore Regional Hospital
Pinehurst North Carolina, 28374, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

30

Study ID:

NCT04735341

Recruitment Status:

Completed

Sponsor:


Intuitive Surgical

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.